UW Research May Lead To Contraceptive Gel To Prevent Chlamydia--The Most Prevalent Sexually Transmitted Disease

December 18, 1996

A University of Washington study may point the way to development of a contraceptive gel to prevent transmission of Chlamydia trachomatis, the most common cause of sexually transmitted disease.

The findings, reported in the mid-December Journal of Clinical Investigation, identify the structure by which chlamydia bacteria attach to and infect cells.

Chlamydia acts like a virus since it must enter a cell to multiply and survive. UW researchers identified the carbohydrate structure which Chlamydia trachomatis uses to connect to and infect host cells as a sugar chain containing 8 or 9 mannose (simple sugar) residues. The research was led by Dr. Cho-chou Kuo and colleague Dr. Sen-itiroh Hakomori, of the UW School of Public Health and Community Medicine.

The discovery was made by using two-dimensional sugar mapping techniques developed by research collaborators in Japan.

With the binding molecule for Chlamydia trachomatis identified, researchers were able to prevent chlamydial infection of cell cultures using similar carbohydrates from known sources. Kuo explains that when cell receptors are saturated with these compounds, molecules carrying chlamydia infection have no point to attach to and, thus, cannot infect the cell.

With these important findings, researchers can now begin work to synthesize a similar carbohydrate to develop anti-adhesive therapies for the prevention of chlamydia, such as contraceptive gels or eye ointments. Chlamydia is also the leading cause of preventable blindness worldwide. Kuo explains such products could be used at times people may be at risk of contracting chlamydia.

The National Institutes of Health estimates that approximately 4 million new cases of sexually transmitted Chlamydia trachomatis infection occur each year in the United States. Symptoms in men and women may be minor and often disappear without treatment. However, the disease will continue to do damage internally. In women, the bacteria damage cells in the reproductive tract, causing inflammation and scarring, leading to infertility and ectopic pregnancy.

Men infected with Chlamydia trachomatis can continue to infect their sexual partners if not treated.

Chlamydial infection can be treated with antibiotics. However, this type of therapy often fails to prevent blindness and infertility due to tissue destruction and can be too costly, or even unavailable, in Third World locations. Kuo explains that a preventive agent included in contraceptive devices could provide an affordable, effective way to reduce the number of chlamydial infections, and subsequent health problems, throughout the world.

# # #

University of Washington

Related Chlamydia Articles from Brightsurf:

Chlamydia: Greedy for glutamine
If chlamydiae want to multiply in a human cell, the first thing they need is a lot of glutamine.

Chlamydia build their own entrance into human cells
Chlamydia, a type of pathogenic bacteria, need to penetrate human cells in order to multiply.

Targeted gene modification in animal pathogenic chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.

How Chlamydia gain access to human cells
Infection biologists at Heinrich Heine University Düsseldorf (HHU) and the University of Freiburg have found out how the LIPP protein discovered in Düsseldorf helps Chlamydia to infect human cells.

Researchers discover how chlamydia takes up new DNA from host
A recent paper by a team of molecular biologists headquartered at the University of Kansas pinpointed a gene that allows chlamydia to take up DNA from its host environment.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

New rapid DNA test to diagnose chlamydia infection in koalas
A new DNA test to detect chlamydia infection in koalas which gives on-the-spot results within 30 minutes has been developed in a collaboration between researchers in Brisbane, Australia.

Researchers identify how vaginal microbiome can elicit resistance to chlamydia
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries.

The Lancet Infectious Diseases: First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response
The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a study published in The Lancet Infectious Diseases journal.

Last chlamydia-free koala population may safeguard future of species
The last, large, isolated, healthy chlamydia-free population of koalas in Australia may have been identified on Kangaroo Island, said Morris Animal Foundation-funded researchers at the University of Adelaide.

Read More: Chlamydia News and Chlamydia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.